NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:NanoPass Technologies Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6583
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoPass Technologies Ltd (NanoPass) is a medical device company that develops and commercializes intradermal delivery solutions for vaccines and drugs. The company’s product include MicronJet600 needle, a single use microneedles based device for intradermal delivery. Its micronjet microneedles are based on micro electro mechanical systems technology and are made of pure silicon crystal. NanoPass’ products are used to inject drugs, proteins, and vaccines directly into the skin. It manufactures hollow microneedles for solid microprojections and intradermal injections for cosmetic enhancement. The company conducts clinical studies in North America, Europe, Israel, Hong Kong, Brazil, Bangladesh, and Japan. It collaborates with vaccine and immunotherapy product developers. NanoPass is headquartered in Nes Ziona, Israel.

NanoPass Technologies Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NanoPass Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NanoPass Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NanoPass Technologies Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
NanoPass Technologies Raises Funds Through Series B Financing 10
Partnerships 11
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 11
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 12
IDRI and NanoPass Tech Enter into Development Agreement 13
Acquisition 14
West Pharma Invests in NanoPass Technologies 14
NanoPass Technologies Ltd – Key Competitors 15
NanoPass Technologies Ltd – Key Employees 16
NanoPass Technologies Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
NanoPass Technologies Ltd, Medical Equipment, Key Facts 2
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NanoPass Technologies Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NanoPass Technologies Ltd, Deals By Market, 2012 to YTD 2018 8
NanoPass Technologies Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NanoPass Technologies Raises Funds Through Series B Financing 10
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 11
NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 12
IDRI and NanoPass Tech Enter into Development Agreement 13
West Pharma Invests in NanoPass Technologies 14
NanoPass Technologies Ltd, Key Competitors 15
NanoPass Technologies Ltd, Key Employees 16

List of Figures
NanoPass Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NanoPass Technologies Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NanoPass Technologies Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
NanoPass Technologies Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NanoPass Technologies Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[NanoPass Technologies Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • Innovent Biologics Inc (1801):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Fieldwood Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Fieldwood Energy LLC (Fieldwood Energy) is an energy and power-focused investment firm. The company operates 500 offshore blocks on the Gulf of Mexico Shelf which focuses on acquiring and developing conventional assets. Fieldwood Energy is portfolio company of Riverstone Holdings LLC. The Co …
  • Briscoe Group Limited (BGP):企業の財務・戦略的SWOT分析
    Briscoe Group Limited (BGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex) formerly Zynex Medical Inc operates as a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential curr …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • EWE AG:石油・ガス:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • TapImmune Inc (TPIV):企業の財務・戦略的SWOT分析
    Summary TapImmune Inc (TapImmune) is a clinical-stage immuno-oncology company focus on the development of innovative peptide, gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease. The company’s pipeline products include TPIV 200, which is intended for the tre …
  • IV Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary IV Diagnostics Inc (IV Diagnostics) is a biomedical company that offers research services. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. …
  • GATC Biotech AG-製薬・医療分野:企業M&A・提携分析
    Summary GATC Biotech AG (GATC Biotech) is a healthcare service center that offers sequencing services. The center products category include nextgen, liquid biopsy, tissue biopsy, sanger and cell culture. It offers nextgen products such as inview transcriptome, inview metagenome, inview microbiome, i …
  • Cathedral Energy Services Ltd (CET):石油・ガス:M&Aディール及び事業提携情報
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, measurement while drilling services, production testing services, …
  • UPM-Kymmene Corporation (UPM):企業の財務・戦略的SWOT分析
    UPM-Kymmene Corporation (UPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析
    Summary Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 …
  • Evonik Industries AG (EVK):企業の財務・戦略的SWOT分析
    Evonik Industries AG (EVK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alembic Pharmaceuticals Ltd (APLLTD):企業の財務・戦略的SWOT分析
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. APL also offers branded formulations in the areas of antibiotics and anti …
  • HealthTronics Inc:企業の戦略的SWOT分析
    HealthTronics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Solvay SA (SOLB):電力:M&Aディール及び事業提携情報
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates. In addition, the company manufactures additives, engineering plastics, diphenols an …
  • Shadin Avionics LP:企業の戦略・SWOT・財務分析
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆